Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...

Enzymes, the core catalysts in life, drive critical biological processes ranging from metabolic regulation to energy ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...

Proteins interacting with cell membranes play a vital role in countless biological processes, from how cells communicate to ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

The tool is said to predict “off-target” effects for seven drugs that could aid in cellular hypertrophy prevention.

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

The Ensuring Pathways to Innovative Cures Act would extend the time Medicare can negotiate and set prices for small molecule ...